Combinatorial epigenetic-based prevention of breast cancer
基于表观遗传学的组合预防乳腺癌
基本信息
- 批准号:10542804
- 负责人:
- 金额:$ 33.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAutomobile DrivingBreast Cancer PreventionBreast Cancer Risk FactorBroccoli - dietaryChemopreventionConceptionsConsumptionDNA Modification MethylasesDNA methyltransferase inhibitionDataDietDiseaseEpigallocatechin GallateEpigenetic ProcessEstrogen declineEstrogen receptor negativeFathersFemaleFetusGene ExpressionGenerationsGenesGerm CellsGoalsGrowthHistone DeacetylaseHistone Deacetylase InhibitorInvestigationLifeMalignant NeoplasmsMediatingMothersMusParentsPreventionPreventiveProcessRegimenRiskRisk ReductionSeveritiesSolidStatistical Data InterpretationSulforaphaneTimeToxic effectTumor SuppressionWomancancer initiationcancer preventioncancer therapycombinatorialdietarydietary approachdietary controlefficacious treatmentepigenomeepigenomicsinnovationmalignant breast neoplasmnovelnovel strategiesoffspringpreventpromoterpublic health relevancesuccesstransgenerational epigenetic inheritancetranslational potentialtumortumor growth
项目摘要
Combinatorial dietary approaches to prevent highly fatal estrogen receptor-negative [ER(-)] breast cancer
(BC) can offer many advantages over single-agent approaches, most notably the potential for greater efficacy
without increased risk of toxicity. We have shown that combined green tea polyphenols that inhibit DNA
methyltransferases and sulforaphane in broccoli sprouts that inhibits histone deacetylases can significantly
delay ER(-) BC initiation and impede its progression at practical and safe dietary levels. Our results have also
shown that the epigenetic machinery is mechanistically important to the efficacy of ER(-) BC prevention
by these diets. Maternal or paternal consumption of this combinatorial regimen can lead to increased latency
and reduced tumor growth in ER(-) BC offspring that have consumed a control diet. Our field-driving studies
show for the first time that this combinatorial diet impacts the epigenome and gene expression of gametes
strongly supporting transgenerational epigenetic effects. Our hypothesis is that combinatorial green tea
polyphenols and sulforaphane-enriched broccoli sprout diets can extend their epigenetic-neutralizing ER(-) BC
preventive effects from one generation to another either through transplacental effects or through
transgenerational effects. These studies will be important to resolving the generational efficacy of
combinatorial cancer prevention and the epigenetic mechanisms through which this effect is mediated. Since
our preliminary findings have indicated that consumption of this combinatorial diet can operate through the
paternal as well as maternal lineage to prevent ER(-) BC in control-fed female offspring, this strongly suggests
that the gametogenic epigenetic changes we have discovered have mechanistic importance for
transgenerational effects in addition to transplacental effects in mothers fed this combinatorial diet. The
paternal effects on epigenetic control of key tumor-related genes by this combinatorial epigenetic-modulating
diet will contribute significantly to elucidation of the mechanisms through which this diet confers preventive
effects on ER(-) BC. One of the goals of this proposed innovative investigation is to resolve the generational
ER(-) BC cancer preventive impact of combinatorial epigenetic-modulating green tea polyphenols and
sulforaphane-enriched broccoli sprouts and the epigenetic and epigenomic mechanisms responsible for their
efficacy. This proposed investigation will have considerable impact in that the consumption of a combined
epigenetic-modulating diet by either the mother or father to delay and reduce ER(-) BC in their offspring would
have broad implications for new perspectives for cancer prevention. Further, ER(-) BC is often recalcitrant to
conventional modes of cancer therapy which significantly increases the importance of means to facilitate its
prevention. Novel approaches to reducing the risk of ER(-) BC through maternal and/or paternal
consumption of this combinatorial diet would contribute significantly to enhanced ER(-) BC prevention
and perhaps preventive control of other cancers worldwide.
预防高度致命的雌激素受体阴性 [ER(-)] 乳腺癌的组合饮食方法
(BC) 比单药方法具有许多优势,最显着的是具有更高功效的潜力
不会增加毒性风险。我们已经证明,组合绿茶多酚可以抑制 DNA
西兰花芽中的甲基转移酶和萝卜硫素可显着抑制组蛋白脱乙酰酶
延迟 ER(-) BC 的发生并在实用且安全的饮食水平下阻止其进展。我们的成果也
研究表明表观遗传机制对于 ER(-) BC 预防的功效具有重要的机制作用
通过这些饮食。母亲或父亲食用这种组合方案可能会导致潜伏期增加
并减少了食用对照饮食的 ER(-) BC 后代的肿瘤生长。我们的实地驱动研究
首次表明这种组合饮食会影响配子的表观基因组和基因表达
强烈支持跨代表观遗传效应。我们的假设是组合绿茶
多酚和富含萝卜硫素的西兰花芽饮食可以延长其表观遗传中和 ER(-) BC
通过胎盘效应或通过
跨代效应。这些研究对于解决代际效率问题非常重要
组合癌症预防以及介导这种效应的表观遗传机制。自从
我们的初步研究结果表明,食用这种组合饮食可以通过
父系和母系血统都可以预防对照喂养的雌性后代中的 ER(-) BC,这强烈表明
我们发现的配子发生表观遗传变化对于
对于喂食这种组合饮食的母亲来说,除了跨胎盘效应之外,还存在跨代效应。这
通过这种组合表观遗传调节对关键肿瘤相关基因的表观遗传控制的父系效应
饮食将极大地有助于阐明这种饮食赋予预防性作用的机制。
对 ER(-) BC 的影响。这项拟议的创新调查的目标之一是解决代际问题
ER(-) 组合表观遗传调节绿茶多酚和 BC 癌症的预防作用
富含萝卜硫素的西兰花芽及其表观遗传和表观基因组机制
功效。这项拟议的调查将产生相当大的影响,因为综合消费
母亲或父亲通过表观遗传调节饮食来延迟和减少后代的 ER(-) BC
对癌症预防的新观点具有广泛的影响。此外,ER(-) BC 常常不同意
癌症治疗的传统模式显着增加了促进其治疗的手段的重要性
预防。通过母亲和/或父亲降低 ER(-) BC 风险的新方法
食用这种组合饮食将大大有助于加强 ER(-) BC 预防
也许还有全世界其他癌症的预防控制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TRYGVE O TOLLEFSBOL其他文献
TRYGVE O TOLLEFSBOL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TRYGVE O TOLLEFSBOL', 18)}}的其他基金
Early life prevention of breast cancer with combined epigenetic botanicals
结合表观遗传植物药物在生命早期预防乳腺癌
- 批准号:
10078944 - 财政年份:2017
- 资助金额:
$ 33.73万 - 项目类别:
Early life prevention of breast cancer with combined epigenetic botanicals
结合表观遗传植物药物在生命早期预防乳腺癌
- 批准号:
9237094 - 财政年份:2017
- 资助金额:
$ 33.73万 - 项目类别:
Combinatorial epigenetic-based prevention of breast cancer
基于表观遗传学的组合预防乳腺癌
- 批准号:
10314068 - 财政年份:2014
- 资助金额:
$ 33.73万 - 项目类别:
Combinatorial epigenetic-based prevention of breast cancer
基于表观遗传学的组合预防乳腺癌
- 批准号:
8829200 - 财政年份:2014
- 资助金额:
$ 33.73万 - 项目类别:
Combinatorial epigenetic-based prevention of breast cancer
基于表观遗传学的组合预防乳腺癌
- 批准号:
8694750 - 财政年份:2014
- 资助金额:
$ 33.73万 - 项目类别:
Combinatorial epigenetic-based prevention of breast cancer
基于表观遗传学的组合预防乳腺癌
- 批准号:
9229516 - 财政年份:2014
- 资助金额:
$ 33.73万 - 项目类别:
Combinatorial epigenetic-based prevention of breast cancer
基于表观遗传学的组合预防乳腺癌
- 批准号:
9015746 - 财政年份:2014
- 资助金额:
$ 33.73万 - 项目类别:
Epigenetics of Tea Polyphenols in Cancer Prevention
茶多酚在癌症预防中的表观遗传学
- 批准号:
8015363 - 财政年份:2008
- 资助金额:
$ 33.73万 - 项目类别:
Epigenetics of Tea Polyphenols in Cancer Prevention
茶多酚在癌症预防中的表观遗传学
- 批准号:
7599223 - 财政年份:2008
- 资助金额:
$ 33.73万 - 项目类别:
Epigenetics of Tea Polyphenols in Cancer Prevention
茶多酚在癌症预防中的表观遗传学
- 批准号:
7762249 - 财政年份:2008
- 资助金额:
$ 33.73万 - 项目类别:
相似国自然基金
基于驾驶人行为理解的人机共驾型智能汽车驾驶权分配机制研究
- 批准号:52302494
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人机共驾汽车驾驶风险分析及控制权智能交互机理
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
定性与定量分析跟驰行驶中汽车驾驶员情感-行为交互作用机理
- 批准号:71901134
- 批准年份:2019
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
兼顾效率与能效的城市道路智能网联汽车驾驶行为优化及实证研究
- 批准号:71871028
- 批准年份:2018
- 资助金额:46.0 万元
- 项目类别:面上项目
汽车驾驶员疲劳的心理生理检测及神经机制
- 批准号:31771225
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Obscurin-Deficient Breast Epithelia Generate Secreted Factors that Prime Lung Vascular Smooth Muscle Cell Pre-metastatic Microenvironment Formation
暗蛋白缺陷的乳腺上皮细胞产生分泌因子,促进肺血管平滑肌细胞转移前微环境的形成
- 批准号:
10749467 - 财政年份:2023
- 资助金额:
$ 33.73万 - 项目类别:
The TGF-Beta/MUC4 Signaling Axis in Circulating Tumor Cells of Metastatic Breast Cancer
转移性乳腺癌循环肿瘤细胞中的 TGF-β/MUC4 信号轴
- 批准号:
10751169 - 财政年份:2023
- 资助金额:
$ 33.73万 - 项目类别:
Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism
癌症生态进化和转移倾向中代谢重连的数学模型
- 批准号:
10582078 - 财政年份:2023
- 资助金额:
$ 33.73万 - 项目类别:
Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci
多效性乳腺癌、前列腺癌和卵巢癌风险位点的共同生物学基础
- 批准号:
10366397 - 财政年份:2022
- 资助金额:
$ 33.73万 - 项目类别:
Developing corrector small molecules for reactivation of mutant p53 in cancer
开发用于重新激活癌症中突变 p53 的校正小分子
- 批准号:
10512976 - 财政年份:2022
- 资助金额:
$ 33.73万 - 项目类别: